Discovery of novel and potent heterocyclic carboxylic acid derivatives as protein tyrosine phosphatase 1B inhibitors
Authors:
- Sujay BasuSBSujay Basu
- Uppuleti Viplava PrasadUPUppuleti Viplava Prasad
- Dinesh A. BarawkarDBDinesh A. Barawkar
- Siddhartha DeSDSiddhartha De
- Venkata P. PalleVPVenkata P. Palle
- Suraj MenonSMSuraj Menon
- Meena PatelMPMeena Patel
- Sachin ThoratSTSachin Thorat
- Umesh P. SinghUSUmesh P. Singh
- Koushik Das SarmaKSKoushik Das Sarma
- Yogesh WamanYWYogesh Waman
- Sanjay NiranjanSNSanjay Niranjan
- 1 April 2012
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 22 (8) , 2843-2849
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Revisiting glitazars: Thiophene substituted oxazole containing α-ethoxy phenylpropanoic acid derivatives as highly potent PPARα/γ dual agonists devoid of adverse effects in rodentsBioorganic & Medicinal Chemistry Letters, 2011
- Discovery of a highly orally bioavailable c-5-[6-(4-Methanesulfonyloxyphenyl)hexyl]-2-methyl-1,3-dioxane-r-2-carboxylic acid as a potent hypoglycemic and hypolipidemic agentBioorganic & Medicinal Chemistry Letters, 2008
- JAK/STAT signal transduction: Regulators and implication in hematological malignanciesBiochemical Pharmacology, 2006
- PPAR ligands: Potential therapies for metabolic syndromeCurrent Diabetes Reports, 2005
- Clinical interest of PPARs ligandsDiabetes & Metabolism, 2004
- PTP1B: From the sidelines to the front lines!FEBS Letters, 2003
- PTP1B inhibitors as potential therapeutics in the treatment of Type 2 diabetes and obesityExpert Opinion on Investigational Drugs, 2003
- Recent Advances in Peroxisome Proliferator-Activated Receptor ScienceCurrent Medicinal Chemistry, 2003
- Insulin signalling and the regulation of glucose and lipid metabolismNature, 2001
- Protein tyrosine phosphatases: their role in insulin action and potential as drug targetsExpert Opinion on Investigational Drugs, 1999